TNF‐Polarized Macrophages Produce Insulin‐like 6 Peptide to Stimulate Bone Formation in Rheumatoid Arthritis in Mice. (18th October 2021)

• Record Type: Journal Article
• Authors: Yi, Xiangjiao; Liu, Xin; Kenney, H Mark; Duan, Rong; Lin, Xi; Schwarz, Edward; Yao, Zhenqiang
• Is Part Of: Journal of bone and mineral research. Volume 36:Number 12(2021)
• Page Start: 2426
• Page End: 2439
• Publication Date: 2021-10-18
• Subjects: ANTI‐TNF THERAPY -- AUTOIMMUNE ARTHRITIS -- BONE TURNOVER -- OSTEOBLAST -- OSTEOCLAST -- OSTEOPOROSIS -- TNF‐TRANSGENIC MICE; Bones -- Metabolism -- Periodicals; Mineral metabolism -- Periodicals; 612.392
• DOI: 10.1002/jbmr.4447
• Languages: English
• ISSNs: 0884-0431

Abstract

ABSTRACT: The risk of osteoporosis is increased in rheumatoid arthritis (RA). Anti‐tumor necrosis factor (TNF) therapy has markedly improved the outcomes of RA patients but does not improve osteoporosis in some reports. This could be a combined result of disease severity and other therapeutic agents, such as glucocorticoids that accelerate osteoporosis progression. We evaluated the effects of anti‐TNF therapy on osteoporosis in an animal model of RA and explored the possible mechanisms involved. Six‐week‐old TNF transgenic (TNF‐Tg) mice with early stage erosive arthritis were treated with TNF antibody (Ab) or control immunoglobulin (IgG) weekly for 4 weeks. We found that TNF Ab completely blocked the development of erosive arthritis in TNF‐Tg mice, but only slightly increased vertebral bone mass, associated with reduction in parameters of both bone resorption and formation. Similarly, TNF Ab slightly increased trabecular bone mass in tibias of 8‐month‐old TNF‐Tg mice with advanced erosive arthritis. Interestingly, TNFα increased osteoblast differentiation from mouse bone marrow stromal cells (BMSCs) containing large number of macrophages but not from pure mesenchymal progenitor cells (MPCs). TNFα‐polarized macrophages (TPMs) did not express iNos and Arginase 1, typical markers of inflammatory and resident macrophages. Interestingly, TPMs stimulated osteoblast differentiation, unlike resident and inflammatory macrophages polarized by IL‐4 and interferon‐λ, respectively. RNA‐seq analysis indicated that TPMs produced several anabolic factors, including Jagged1 and insulin like 6 (INSL6). Importantly, inhibition of either Jagged1 or INSL6 blocked TNFα‐induced osteoblast differentiation. Furthermore, INSL6 Ab significantly decreased the expansion of TNF‐induced MPCs in BMSCs, and anti‐TNF Ab reduced INSL6 expression by macrophages in vitro and in TNF‐Tg mice in vivo. We conclude that TPMs produce INSL6 to stimulate bone formation and anti‐TNF Ab blocks not only enhanced bone resorption but also the anabolic effect of TPMs on bone, limiting its effect to increase bone mass in this model of RA. © 2021 American Society for Bone and Mineral Research (ASBMR).